📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Anadys Pharmaceuticals

1.1 - Company Overview

Anadys Pharmaceuticals Logo

Anadys Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical therapeutics for chronic hepatitis C, developing ANA598, a direct-acting antiviral (DAA), and resuming clinical development of ANA773.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Anadys Pharmaceuticals

Enochian Biopharma Logo

Enochian Biopharma

HQ: United States Website
  • Description: Provider of biotechnology, operating as a biotechnology company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enochian Biopharma company profile →
Targanta Therapeutics Logo

Targanta Therapeutics

HQ: United States Website
  • Description: Provider of innovative antibiotics and antibacterial therapies for serious infections treated or acquired in hospitals and other institutional settings, including oritavancin, an intravenous bactericidal agent for Gram-positive infections with Phase III trials for complicated skin and skin structure infections; antibacterial pro-drugs for osteomyelitis; and a drug discovery platform that mimics strategies devised by bacterial viruses to target druggable bacterial mechanisms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Targanta Therapeutics company profile →
Bioquell Logo

Bioquell

HQ: United Kingdom Website
  • Description: Provider of biodecontamination systems and services specializing in Hydrogen Peroxide Vapor technology to eliminate bacteria, viruses, fungi, and spores. Products include Bioquell Hydrogen Peroxide Vapour Decontamination (35% H2O2 vapor for surface and airborne pathogen elimination), Rapid Bio-Decontamination Service, ProteQ automated room decontamination, and Qube isolators for sterility testing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bioquell company profile →
Amicrobe Logo

Amicrobe

HQ: United States Website
  • Description: Provider of advanced biomaterials to prevent and treat infections, offering Amicidin-α Surgical gel for clean and clean-contaminated surgical procedures; Amicidin-β Solution for contaminated and infected tissues with tissue cleansing and microbicidal activity; Amicidin-α PFC for military prolonged field settings (up to 72 hours); and Amicidin-β/EF for emergency settings, including trauma and emergency cesarean delivery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amicrobe company profile →
OnCore Biopharma Logo

OnCore Biopharma

HQ: United States Website
  • Description: Provider of biotechnology research, development, and commercialization of therapies for chronic hepatitis B virus (HBV) infection, assembling a portfolio of novel product candidates with unique mechanisms of action for the treatment of hepatitis B.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OnCore Biopharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Anadys Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Anadys Pharmaceuticals

2.2 - Growth funds investing in similar companies to Anadys Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Anadys Pharmaceuticals

4.2 - Public trading comparable groups for Anadys Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Anadys Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Anadys Pharmaceuticals

What does Anadys Pharmaceuticals do?

Anadys Pharmaceuticals is a provider of biopharmaceutical therapeutics for chronic hepatitis C, developing ANA598, a direct-acting antiviral (DAA), and resuming clinical development of ANA773.

Who are Anadys Pharmaceuticals's competitors?

Anadys Pharmaceuticals's competitors and similar companies include Enochian Biopharma, Targanta Therapeutics, Bioquell, Amicrobe, and OnCore Biopharma.

Where is Anadys Pharmaceuticals headquartered?

Anadys Pharmaceuticals is headquartered in United States.

How many employees does Anadys Pharmaceuticals have?

Anadys Pharmaceuticals has 1,000 employees 🔒.

When was Anadys Pharmaceuticals founded?

Anadys Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Anadys Pharmaceuticals in?

Anadys Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Anadys Pharmaceuticals

Who are the top strategic acquirers in Anadys Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Anadys Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Anadys Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Anadys Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Anadys Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Anadys Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Anadys Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Anadys Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Anadys Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Anadys Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Anadys Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Anadys Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Anadys Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Anadys Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Anadys Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Anadys Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Anadys Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Anadys Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Anadys Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Anadys Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Anadys Pharmaceuticals